Youwen Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Youwen Zhang has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Hippokratis Kiaris
Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina
4 shared publications - Alan G. Barbour
Department of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, Irvine, CA, United States
2 shared publications - Ali Mortazavi
Developmental and Cell Biology, University of California Irvine, Irvine, USA
2 shared publications - Ana Milovic
Department of Microbiology & Molecular Genetics University of California Irvine
2 shared publications - Gabriela Balderrama-Gutierrez
University of California, Irvine
2 shared publications - John T. Belisle
Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, USA
2 shared publications
Latest Publications
- Open Access
- 30 July 2023
- Published by BMJ
- Vol. 15 (Suppl 1) , A113
E-064 A rare case of solitary isolated dural metastasis from hepatocellular carcinoma mimicking a meningioma
Introduction Meningiomas are the most common primary tumors, accounting for 35% of all intracranial neoplasms. Most are benign, clinically silent masses that are incidentally found on imaging as a solitary, focal lesion. However, there are reports of other extra-axial metastatic tumors in the dura and leptomeninges mimicking meningiomas that are misdiagnosed on imaging. Though rare, metastases to the dura have previously been characterized as late manifestations of an underlying primary malignancy and is associated with a poor prognosis. Metastases from a primary malignancy of the lung, breast, and prostate account for the majority of cases. However, dural metastasis from hepatocellular carcinoma (HCC) is extremely rare. Here we present a case of solitary, isolated dural metastasis from an underlying HCC mimicking a meningioma. Methods N/A Results Patient was a 64-year-old male who presented to the ED with 3 days of altered mental status and 12-day history of right sided weakness and dysarthria. Upon examination, there was presence of right hemiparesis with left gaze preference and was nonverbal and unable to follow commands. He was intubated for acute hypoxemic respiratory failure and was subsequently transferred to the ICU. MRI revealed a 5.8 cm enhancing left dural parafalcine hemorrhagic mass extending across the midline with significant vasogenic edema. and cerebral angiogram demonstrated the presence of a left ACA pseudoaneurysm within the mass receiving input from the left ophthalmic artery and right middle meningeal artery. The patient underwent embolization of the ACA pseudoaneurysm and resection of the parafalcine mass with no complications. Tumor pathology revealed a poorly differentiated carcinoma of the dura, consistent with metastatic hepatocellular carcinoma. The patient failed to demonstrate further neurological recovery and expired on day 18 of hospitalization. Conclusions Solitary, isolated metastasis to the dura mater is a very rare manifestation of HCC and is seldom its initial clinical presentation. HCC initially spreads contiguously through the portal and hepatic veins followed by the regional lymph nodes. Intravasation into the veins subsequently leads to pulmonary vascular metastasis into the lungs, the most common extrahepatic metastatic site, followed by the bones and adrenal glands. The CNS is hypothesized to be the next most common site of HCC metastasis. Diagnosis of dural metastasis challenging as they are often difficult to distinguish from meningiomas on imaging. Both dural metastases and meningiomas may present as contrast enhancing, homogeneous lesions with a dural tail sign and vasogenic edema. Features specific to dural metastases include lower relative CBV on PWI and absence of alanine peaks on MR spectroscopy. Chronic subdural hematomas may also be present in 15-40% of cases. With advancements in cancer diagnoses and treatments resulting in increased survival time, it is crucial to remain aware of the possibility of dural metastasis masquerading as a meningioma. Disclosures J. Choi: None. Y. Zhang: None. F. Hui: None. S. Brown: None. S. Tsappidi: None.
- 30 July 2023
- Published by BMJ
- Vol. 15 (Suppl 1) , A113
Open AccessE-064 A rare case of solitary isolated dural metastasis from hepatocellular carcinoma mimicking a meningioma
Introduction Meningiomas are the most common primary tumors, accounting for 35% of all intracranial neoplasms. Most are benign, clinically silent masses that are incidentally found on imaging as a solitary, focal lesion. However, there are reports of other extra-axial metastatic tumors in the dura and leptomeninges mimicking meningiomas that are misdiagnosed on imaging. Though rare, metastases to the dura have previously been characterized as late manifestations of an underlying primary malignancy and is associated with a poor prognosis. Metastases from a primary malignancy of the lung, breast, and prostate account for the majority of cases. However, dural metastasis from hepatocellular carcinoma (HCC) is extremely rare. Here we present a case of solitary, isolated dural metastasis from an underlying HCC mimicking a meningioma. Methods N/A Results Patient was a 64-year-old male who presented to the ED with 3 days of altered mental status and 12-day history of right sided weakness and dysarthria. Upon examination, there was presence of right hemiparesis with left gaze preference and was nonverbal and unable to follow commands. He was intubated for acute hypoxemic respiratory failure and was subsequently transferred to the ICU. MRI revealed a 5.8 cm enhancing left dural parafalcine hemorrhagic mass extending across the midline with significant vasogenic edema. and cerebral angiogram demonstrated the presence of a left ACA pseudoaneurysm within the mass receiving input from the left ophthalmic artery and right middle meningeal artery. The patient underwent embolization of the ACA pseudoaneurysm and resection of the parafalcine mass with no complications. Tumor pathology revealed a poorly differentiated carcinoma of the dura, consistent with metastatic hepatocellular carcinoma. The patient failed to demonstrate further neurological recovery and expired on day 18 of hospitalization. Conclusions Solitary, isolated metastasis to the dura mater is a very rare manifestation of HCC and is seldom its initial clinical presentation. HCC initially spreads contiguously through the portal and hepatic veins followed by the regional lymph nodes. Intravasation into the veins subsequently leads to pulmonary vascular metastasis into the lungs, the most common extrahepatic metastatic site, followed by the bones and adrenal glands. The CNS is hypothesized to be the next most common site of HCC metastasis. Diagnosis of dural metastasis challenging as they are often difficult to distinguish from meningiomas on imaging. Both dural metastases and meningiomas may present as contrast enhancing, homogeneous lesions with a dural tail sign and vasogenic edema. Features specific to dural metastases include lower relative CBV on PWI and absence of alanine peaks on MR spectroscopy. Chronic subdural hematomas may also be present in 15-40% of cases. With advancements in cancer diagnoses and treatments resulting in increased survival time, it is crucial to remain aware of the possibility of dural metastasis masquerading as a meningioma. Disclosures J. Choi: None. Y. Zhang: None. F. Hui: None. S. Brown: None. S. Tsappidi: None.
- Open Access
- 14 February 2023
- Published by Wiley in FEBS Open Bio
- Vol. 13 (3) , 556-569
RASSF1 is identified by transcriptome coordination analysis as a target of ATF4
Evaluation of gene co-regulation is a powerful approach for revealing regulatory associations between genes and predicting biological function, especially in genetically diverse samples. Here, we applied this strategy to identify transcripts that are co-regulated with unfolded protein response (UPR) genes in cultured fibroblasts from outbred deer mice. Our analyses showed that the transcriptome associated with RASSF1, a tumor suppressor involved in cell cycle regulation and not previously linked to UPR, is highly correlated with the transcriptome of several UPR-related genes, such as BiP/GRP78, DNAJB9, GRP94, ATF4, DNAJC3, and CHOP/DDIT3. Conversely, gene ontology analyses for genes co-regulated with RASSF1 predicted a previously unreported involvement in UPR-associated apoptosis. Bioinformatic analyses indicated the presence of ATF4-binding sites in the RASSF1 promoter, which were shown to be operational using chromatin immunoprecipitation. Reporter assays revealed that the RASSF1 promoter is responsive to ATF4, while ablation of RASSF1 mitigated the expression of the ATF4 effector BBC3 and abrogated tunicamycin-induced apoptosis. Collectively, these results implicate RASSF1 in the regulation of endoplasmic reticulum stress-associated apoptosis downstream of ATF4. They also illustrate the power of gene coordination analysis in predicting biological functions and revealing regulatory associations between genes.
- 14 February 2023
- Published by Wiley in FEBS Open Bio
- Vol. 13 (3) , 556-569
Open AccessRASSF1 is identified by transcriptome coordination analysis as a target of ATF4
Evaluation of gene co-regulation is a powerful approach for revealing regulatory associations between genes and predicting biological function, especially in genetically diverse samples. Here, we applied this strategy to identify transcripts that are co-regulated with unfolded protein response (UPR) genes in cultured fibroblasts from outbred deer mice. Our analyses showed that the transcriptome associated with RASSF1, a tumor suppressor involved in cell cycle regulation and not previously linked to UPR, is highly correlated with the transcriptome of several UPR-related genes, such as BiP/GRP78, DNAJB9, GRP94, ATF4, DNAJC3, and CHOP/DDIT3. Conversely, gene ontology analyses for genes co-regulated with RASSF1 predicted a previously unreported involvement in UPR-associated apoptosis. Bioinformatic analyses indicated the presence of ATF4-binding sites in the RASSF1 promoter, which were shown to be operational using chromatin immunoprecipitation. Reporter assays revealed that the RASSF1 promoter is responsive to ATF4, while ablation of RASSF1 mitigated the expression of the ATF4 effector BBC3 and abrogated tunicamycin-induced apoptosis. Collectively, these results implicate RASSF1 in the regulation of endoplasmic reticulum stress-associated apoptosis downstream of ATF4. They also illustrate the power of gene coordination analysis in predicting biological functions and revealing regulatory associations between genes.
- Open Access
- 13 June 2022
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 79 (8) , 808-816
Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults
Immune-mediated rippling muscle disease (iRMD) is a rare myopathy characterized by abnormal muscle excitability. It is usually electrically silent, exhibiting wavelike muscle contractions (rippling) and percussion- or stretch-induced muscle mounding.1 In contrast to hereditary rippling muscle disease (hRMD), associated to date with pathogenic variants in caveolin-3 (CAV3) or, less frequently, cavin-1 (CAVIN1) genes, patients with iRMD lack a defined genetic defect.2,3 Responsiveness to immunotherapy supports an autoimmune pathogenesis. Muscle acetylcholine receptor antibody positivity with or without clinical myasthenia gravis (MG) has been reported in association with iRMD, further favoring its potential immune-mediated etiology.4-6
- 13 June 2022
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 79 (8) , 808-816
Open AccessIdentification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults
Immune-mediated rippling muscle disease (iRMD) is a rare myopathy characterized by abnormal muscle excitability. It is usually electrically silent, exhibiting wavelike muscle contractions (rippling) and percussion- or stretch-induced muscle mounding.1 In contrast to hereditary rippling muscle disease (hRMD), associated to date with pathogenic variants in caveolin-3 (CAV3) or, less frequently, cavin-1 (CAVIN1) genes, patients with iRMD lack a defined genetic defect.2,3 Responsiveness to immunotherapy supports an autoimmune pathogenesis. Muscle acetylcholine receptor antibody positivity with or without clinical myasthenia gravis (MG) has been reported in association with iRMD, further favoring its potential immune-mediated etiology.4-6
- Open Access
- 14 September 2021
- Published by Springer Nature in BMC Genomics
- Vol. 22 (1) , 1-15
Genomic variation in captive deer mouse (Peromyscus maniculatus) populations
Background: Deer mice (genus Peromyscus) are the most common rodents in North America. Despite the availability of reference genomes for some species, a comprehensive database of polymorphisms, especially in those maintained as living stocks and distributed to academic investigators, is missing. In the present study we surveyed two populations of P. maniculatus that are maintained at the Peromyscus Genetic Stock Center (PGSC) for polymorphisms across their 2.5 × 109 bp genome. Results: High density of variation was identified, corresponding to one SNP every 55 bp for the high altitude stock (SM2) or 207 bp for the low altitude stock (BW) using snpEff (v4.3). Indels were detected every 1157 bp for BW or 311 bp for SM2. The average Watterson estimator for the BW and SM2 populations is 248813.70388 and 869071.7671 respectively. Some differences in the distribution of missense, nonsense and silent mutations were identified between the stocks, as well as polymorphisms in genes associated with inflammation (NFATC2), hypoxia (HIF1a) and cholesterol metabolism (INSIG1) and may possess value in modeling pathology. Conclusions: This genomic resource, in combination with the availability of P. maniculatus from the PGSC, is expected to promote genetic and genomic studies with this animal model.
- 14 September 2021
- Published by Springer Nature in BMC Genomics
- Vol. 22 (1) , 1-15
Open AccessGenomic variation in captive deer mouse (Peromyscus maniculatus) populations
Background: Deer mice (genus Peromyscus) are the most common rodents in North America. Despite the availability of reference genomes for some species, a comprehensive database of polymorphisms, especially in those maintained as living stocks and distributed to academic investigators, is missing. In the present study we surveyed two populations of P. maniculatus that are maintained at the Peromyscus Genetic Stock Center (PGSC) for polymorphisms across their 2.5 × 109 bp genome. Results: High density of variation was identified, corresponding to one SNP every 55 bp for the high altitude stock (SM2) or 207 bp for the low altitude stock (BW) using snpEff (v4.3). Indels were detected every 1157 bp for BW or 311 bp for SM2. The average Watterson estimator for the BW and SM2 populations is 248813.70388 and 869071.7671 respectively. Some differences in the distribution of missense, nonsense and silent mutations were identified between the stocks, as well as polymorphisms in genes associated with inflammation (NFATC2), hypoxia (HIF1a) and cholesterol metabolism (INSIG1) and may possess value in modeling pathology. Conclusions: This genomic resource, in combination with the availability of P. maniculatus from the PGSC, is expected to promote genetic and genomic studies with this animal model.
- Open Access
- 27 April 2021
- Published by American Society for Microbiology in mBio
- Vol. 12 (2)
An Infection-Tolerant Mammalian Reservoir for Several Zoonotic Agents Broadly Counters the Inflammatory Effects of Endotoxin
Animals that are competent reservoirs of zoonotic pathogens commonly suffer little morbidity from the infections. To investigate mechanisms of this tolerance of infection, we used single-dose lipopolysaccharide (LPS) as an experimental model of inflammation and compared the responses of two rodents: Peromyscus leucopus, the white-footed deermouse and reservoir for the agents of Lyme disease and other zoonoses, and the house mouse Mus musculus. Four hours after injection with LPS or saline, blood, spleen, and liver samples were collected and subjected to transcriptome sequencing (RNA-seq), metabolomics, and specific reverse transcriptase quantitative PCR (RT-qPCR). Differential expression analysis was at the gene, pathway, and network levels. LPS-treated deermice showed signs of sickness similar to those of exposed mice and had similar increases in corticosterone levels and expression of interleukin 6 (IL-6), tumor necrosis factor, IL-1β, and C-reactive protein. By network analysis, the M. musculus response to LPS was characterized as cytokine associated, while the P. leucopus response was dominated by neutrophil activity terms. In addition, dichotomies in the expression levels of arginase 1 and nitric oxide synthase 2 and of IL-10 and IL-12 were consistent with type M1 macrophage responses in mice and type M2 responses in deermice. Analysis of metabolites in plasma and RNA in organs revealed species differences in tryptophan metabolism. Two genes in particular signified the different phenotypes of deermice and mice: the Slpi and Ibsp genes. Key RNA-seq findings for P. leucopus were replicated in older animals, in a systemic bacterial infection, and with cultivated fibroblasts. The findings indicate that P. leucopus possesses several adaptive traits to moderate inflammation in its balancing of infection resistance and tolerance. IMPORTANCE Animals that are natural carriers of pathogens that cause human diseases commonly manifest little or no sickness as a consequence of infection. Examples include the deermouse, Peromyscus leucopus, which is a reservoir for Lyme disease and several other disease agents in North America, and some types of bats, which are carriers of viruses with pathogenicity for humans. Mechanisms of this phenomenon of infection tolerance and entailed trade-off costs are poorly understood. Using a single injection of lipopolysaccharide (LPS) endotoxin as a proxy for infection, we found that deermice differed from the mouse (Mus musculus) in responses to LPS in several diverse pathways, including innate immunity, oxidative stress, and metabolism. Features distinguishing the deermice cumulatively would moderate downstream ill effects of LPS. Insights gained from the P. leucopus model in the laboratory have implications for studying infection tolerance in other important reservoir species, including bats and other types of wildlife.
- 27 April 2021
- Published by American Society for Microbiology in mBio
- Vol. 12 (2)
Open AccessAn Infection-Tolerant Mammalian Reservoir for Several Zoonotic Agents Broadly Counters the Inflammatory Effects of Endotoxin
Animals that are competent reservoirs of zoonotic pathogens commonly suffer little morbidity from the infections. To investigate mechanisms of this tolerance of infection, we used single-dose lipopolysaccharide (LPS) as an experimental model of inflammation and compared the responses of two rodents: Peromyscus leucopus, the white-footed deermouse and reservoir for the agents of Lyme disease and other zoonoses, and the house mouse Mus musculus. Four hours after injection with LPS or saline, blood, spleen, and liver samples were collected and subjected to transcriptome sequencing (RNA-seq), metabolomics, and specific reverse transcriptase quantitative PCR (RT-qPCR). Differential expression analysis was at the gene, pathway, and network levels. LPS-treated deermice showed signs of sickness similar to those of exposed mice and had similar increases in corticosterone levels and expression of interleukin 6 (IL-6), tumor necrosis factor, IL-1β, and C-reactive protein. By network analysis, the M. musculus response to LPS was characterized as cytokine associated, while the P. leucopus response was dominated by neutrophil activity terms. In addition, dichotomies in the expression levels of arginase 1 and nitric oxide synthase 2 and of IL-10 and IL-12 were consistent with type M1 macrophage responses in mice and type M2 responses in deermice. Analysis of metabolites in plasma and RNA in organs revealed species differences in tryptophan metabolism. Two genes in particular signified the different phenotypes of deermice and mice: the Slpi and Ibsp genes. Key RNA-seq findings for P. leucopus were replicated in older animals, in a systemic bacterial infection, and with cultivated fibroblasts. The findings indicate that P. leucopus possesses several adaptive traits to moderate inflammation in its balancing of infection resistance and tolerance. IMPORTANCE Animals that are natural carriers of pathogens that cause human diseases commonly manifest little or no sickness as a consequence of infection. Examples include the deermouse, Peromyscus leucopus, which is a reservoir for Lyme disease and several other disease agents in North America, and some types of bats, which are carriers of viruses with pathogenicity for humans. Mechanisms of this phenomenon of infection tolerance and entailed trade-off costs are poorly understood. Using a single injection of lipopolysaccharide (LPS) endotoxin as a proxy for infection, we found that deermice differed from the mouse (Mus musculus) in responses to LPS in several diverse pathways, including innate immunity, oxidative stress, and metabolism. Features distinguishing the deermice cumulatively would moderate downstream ill effects of LPS. Insights gained from the P. leucopus model in the laboratory have implications for studying infection tolerance in other important reservoir species, including bats and other types of wildlife.
- Open Access
The infection-tolerant mammalian reservoir of Lyme disease and other zoonoses broadly counters the inflammatory effects of endotoxin
Animals that are competent natural reservoirs of zoonotic diseases commonly suffer little morbidity from the pathogens they persistently harbor. The mechanisms of this infection tolerance and the trade-off costs are poorly understood. We used exposure to a single dose of lipopolysaccharide (LPS) endotoxin as an experimental model of inflammation to compare the responses of the cricentine rodent Peromyscus leucopus , the white-footed deermouse, to that of Mus musculus , the standard laboratory model for pathogenesis studies. Four hours after injection with either LPS or saline, blood and spleen and liver tissues were collected postmortem and subjected to RNA-seq, untargeted metabolomics, and specific RT-qPCR. This was followed by analysis of differential expression at the gene, pathway, and empirical network levels. The deermice showed the same signs of sickness as the mice with LPS exposure, and in addition demonstrated comparable increases in levels of corticosterone and expression of interleukin (IL)-6, tumor necrosis factor, IL-1β, and acute phase reactants, including C-reactive protein. But whereas the M. musculus response to LPS was best-characterized by network analysis as cytokine-associated, the P. leucopus response was dominated by pathway terms associated with neutrophil activity. Dichotomies between the species in expression profiles of arginase 1 and nitric oxide synthase 2, as well as the ratios of IL-10 to IL-12, were consistent with a type M1 polarized macrophage response in the mice and a type M2 or alternatively-activated response in the deermice. Analysis of metabolites in the plasma and RNA in the tissues revealed differences between the two species in tryptophan metabolism during response to LPS. Two up-regulated genes in particular signified the difference between the species: Slpi (secretory leukocyte proteinase inhibitor) and Ibsp (integrin-binding protein sialoprotein). The latter was previously unrecognized in the context of inflammation or infection. Key RNA-seq findings in P. leucopus were replicated in a second LPS experiment with older animals, in a systemic bacterial infection model, and with cultivated fibroblasts. Taken together, the results indicate that the deermouse possesses several adaptive traits to moderate effects of inflammation and oxidative stress ensuing from infection. This seems to be at the cost of infection persistence and that is to the benefit of the pathogen.
Open AccessThe infection-tolerant mammalian reservoir of Lyme disease and other zoonoses broadly counters the inflammatory effects of endotoxin
Animals that are competent natural reservoirs of zoonotic diseases commonly suffer little morbidity from the pathogens they persistently harbor. The mechanisms of this infection tolerance and the trade-off costs are poorly understood. We used exposure to a single dose of lipopolysaccharide (LPS) endotoxin as an experimental model of inflammation to compare the responses of the cricentine rodent Peromyscus leucopus , the white-footed deermouse, to that of Mus musculus , the standard laboratory model for pathogenesis studies. Four hours after injection with either LPS or saline, blood and spleen and liver tissues were collected postmortem and subjected to RNA-seq, untargeted metabolomics, and specific RT-qPCR. This was followed by analysis of differential expression at the gene, pathway, and empirical network levels. The deermice showed the same signs of sickness as the mice with LPS exposure, and in addition demonstrated comparable increases in levels of corticosterone and expression of interleukin (IL)-6, tumor necrosis factor, IL-1β, and acute phase reactants, including C-reactive protein. But whereas the M. musculus response to LPS was best-characterized by network analysis as cytokine-associated, the P. leucopus response was dominated by pathway terms associated with neutrophil activity. Dichotomies between the species in expression profiles of arginase 1 and nitric oxide synthase 2, as well as the ratios of IL-10 to IL-12, were consistent with a type M1 polarized macrophage response in the mice and a type M2 or alternatively-activated response in the deermice. Analysis of metabolites in the plasma and RNA in the tissues revealed differences between the two species in tryptophan metabolism during response to LPS. Two up-regulated genes in particular signified the difference between the species: Slpi (secretory leukocyte proteinase inhibitor) and Ibsp (integrin-binding protein sialoprotein). The latter was previously unrecognized in the context of inflammation or infection. Key RNA-seq findings in P. leucopus were replicated in a second LPS experiment with older animals, in a systemic bacterial infection model, and with cultivated fibroblasts. Taken together, the results indicate that the deermouse possesses several adaptive traits to moderate effects of inflammation and oxidative stress ensuing from infection. This seems to be at the cost of infection persistence and that is to the benefit of the pathogen.